Prevalence of Age Related Maculopathy in a Representative Japanese Population: the Hisayama Study

Overview

Journal Br J Ophthalmol

Specialty Ophthalmology

Date 2001 Sep 25

PMID 11567955

Citations 69

Authors

Y Oshima

T Ishibashi

T Murata

Y Tahara

Y Kiyohara

T Kubota

Affiliations

Soon will be listed here.

Abstract

Aim: To determine the prevalence of age related maculopathy (ARM) in a representative older Japanese population.

Methods: 1486 residents of Hisayama town, Fukuoka, Japan, aged 50 years or older were examined and the presence of ARM was determined by grading from fundus examination by indirect ophthalmoscope, slit lamp, and colour fundus photographs.

Results: The prevalence rate of drusen, which occurred with comparable frequency in men and women, was 9.6%. The frequency of drusen increased with age (p <0.01). Hyperpigmentation and/or hypopigmentation of the retina was present in 3.2%, geographic atrophy in 0.2%, and neovascular age related macular degeneration in 0.67%. The frequency of neovascular age related macular degeneration was significantly higher in the men (1.2% v. 0.34%, p <0.01).

Conclusions: Early and late stage ARM is less common among Japanese people than among white people in Western countries, while late stage ARM is more common among Japanese than among black people.

Citing Articles

Recurrence Rate during 5-Year Period after Suspension of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.

Chujo S, Matsubara H, Mase Y, Kato K, Kondo M J Clin Med. 2024; 13(15).

PMID: 39124583 PMC: 11312843. DOI: 10.3390/jcm13154317.

Androgen Deprivation Therapy and Newly Developed Neovascular Age-Related Macular Degeneration Risk in Patients with Prostate Cancer.

Ha J, Kim D, Lee H, Jeon S, Jeon J, Kim D J Clin Med. 2024; 13(10).

PMID: 38792519 PMC: 11121844. DOI: 10.3390/jcm13102978.

Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (Study of Health in Pomerania-TREND-1).

Ludtke L, Ittermann T, Grossjohann R, Jurgens C, Volzke H, Tost F Med Sci Monit. 2024; 30:e943140.

PMID: 38702879 PMC: 11078065. DOI: 10.12659/MSM.943140.

Scleritis following intravitreal brolucizumab injection: a case series.

Takayama T, Inoda S, Takahashi H, Tsukii R, Yoshida H, Kasuya Y J Med Case Rep. 2024; 18(1):80.

PMID: 38419100 PMC: 10902930. DOI: 10.1186/s13256-024-04402-9.

Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration.

Chujo S, Matsubara H, Matsui Y, Sugimoto M, Kondo M J Clin Med. 2023; 12(11).

PMID: 37297855 PMC: 10253655. DOI: 10.3390/jcm12113659.

References

LEIBOWITZ H, KRUEGER D, Maunder L, Milton R, KINI M, KAHN H . The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980; 24(Suppl):335-610. View

Bressler N, Bressler S, West S, Fine S, Taylor H . The grading and prevalence of macular degeneration in Chesapeake Bay watermen. Arch Ophthalmol. 1989; 107(6):847-52. DOI: 10.1001/archopht.1989.01070010869032. View

Klein R, Davis M, Magli Y, Segal P, Klein B, Hubbard L . The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98(7):1128-34. DOI: 10.1016/s0161-6420(91)32186-9. View

Klein R, Klein B, Linton K . Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology. 1992; 99(6):933-43. DOI: 10.1016/s0161-6420(92)31871-8. View

Klein R, Meuer S, Moss S, Klein B . Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology. 1992; 99(11):1686-92. DOI: 10.1016/s0161-6420(92)31745-2. View

Ohmura T, Ueda K, Kiyohara Y, Kato I, Iwamoto H, Nakayama K . Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama Study. Diabetologia. 1993; 36(11):1198-203. DOI: 10.1007/BF00401066. View

Vingerling J, Dielemans I, Hofman A, Grobbee D, Hijmering M, Kramer C . The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995; 102(2):205-10. DOI: 10.1016/s0161-6420(95)31034-2. View

Klein R, Rowland M, Harris M . Racial/ethnic differences in age-related maculopathy. Third National Health and Nutrition Examination Survey. Ophthalmology. 1995; 102(3):371-81. DOI: 10.1016/s0161-6420(95)31012-3. View

Schachat A, Hyman L, Leske M, Connell A, Wu S . Features of age-related macular degeneration in a black population. The Barbados Eye Study Group. Arch Ophthalmol. 1995; 113(6):728-35. DOI: 10.1001/archopht.1995.01100060054032. View

10.

Bird A, Bressler N, Bressler S, Chisholm I, Coscas G, Davis M . An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995; 39(5):367-74. DOI: 10.1016/s0039-6257(05)80092-x. View

11.

Vingerling J, Hofman A, Grobbee D, de Jong P . Age-related macular degeneration and smoking. The Rotterdam Study. Arch Ophthalmol. 1996; 114(10):1193-6. DOI: 10.1001/archopht.1996.01100140393005. View

12.

Smith W, Mitchell P, Leeder S . Smoking and age-related maculopathy. The Blue Mountains Eye Study. Arch Ophthalmol. 1996; 114(12):1518-23. DOI: 10.1001/archopht.1996.01100140716016. View

13.

Mitchell P, Smith W, Attebo K, Wang J . Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology. 1995; 102(10):1450-60. DOI: 10.1016/s0161-6420(95)30846-9. View

14.

Yuzawa M, Tamakoshi A, Kawamura T, Ohno Y, Uyama M, Honda T . Report on the nationwide epidemiological survey of exudative age-related macular degeneration in Japan. Int Ophthalmol. 1997; 21(1):1-3. DOI: 10.1023/a:1005845521424. View

15.

Tamakoshi A, Yuzawa M, Matsui M, Uyama M, Fujiwara N, Ohno Y . Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. Research Committee on Chorioretinal Degenerations. Br J Ophthalmol. 1998; 81(10):901-4. PMC: 1722029. DOI: 10.1136/bjo.81.10.901. View

16.

Friedman D, Katz J, Bressler N, Rahmani B, Tielsch J . Racial differences in the prevalence of age-related macular degeneration: the Baltimore Eye Survey. Ophthalmology. 1999; 106(6):1049-55. DOI: 10.1016/S0161-6420(99)90267-1. View

17.

Klein R, Klein B, Jensen S, Cruickshanks K, Palta M . Age-related maculopathy in a multiracial United States population: the National Health and Nutrition Examination Survey III. Ophthalmology. 1999; 106(6):1056-65. DOI: 10.1016/S0161-6420(99)90255-5. View

18.

Iwamoto H, Kiyohara Y, Fujishima M, Kato I, Nakayama K, Sueishi K . Prevalence of intracranial saccular aneurysms in a Japanese community based on a consecutive autopsy series during a 30-year observation period. The Hisayama study. Stroke. 1999; 30(7):1390-5. DOI: 10.1161/01.str.30.7.1390. View

19.

Wu L . Study of aging macular degeneration in China. Jpn J Ophthalmol. 1987; 31(3):349-67. View